Revisión
Resistencias al tratamiento no quirúrgico en cáncer cutáneo no melanoma. Parte II: terapia fotodinámica, vismodegib, cetuximab, metotrexato intralesional y radioterapia
Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part II: Photodynamic Therapy, Vismodegib, Cetuximab, Intralesional Methotrexate, and Radiotherapy
Leído
8989
Vecesse ha leído el artículo
2482
Total PDF
6507
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 14 | 2 | 16 |
| 2025 5 | 155 | 35 | 190 |
| 2025 4 | 131 | 20 | 151 |
| 2025 3 | 134 | 29 | 163 |
| 2025 2 | 201 | 43 | 244 |
| 2025 1 | 127 | 39 | 166 |
| 2024 12 | 104 | 36 | 140 |
| 2024 11 | 100 | 76 | 176 |
| 2024 10 | 91 | 60 | 151 |
| 2024 9 | 79 | 32 | 111 |
| 2024 8 | 103 | 61 | 164 |
| 2024 7 | 94 | 35 | 129 |
| 2024 6 | 106 | 44 | 150 |
| 2024 5 | 103 | 28 | 131 |
| 2024 4 | 98 | 35 | 133 |
| 2024 3 | 86 | 23 | 109 |
| 2024 2 | 62 | 37 | 99 |
| 2024 1 | 94 | 26 | 120 |
| 2023 12 | 73 | 13 | 86 |
| 2023 11 | 83 | 28 | 111 |
| 2023 10 | 69 | 23 | 92 |
| 2023 9 | 78 | 34 | 112 |
| 2023 8 | 62 | 20 | 82 |
| 2023 7 | 77 | 47 | 124 |
| 2023 6 | 67 | 23 | 90 |
| 2023 5 | 84 | 27 | 111 |
| 2023 4 | 51 | 32 | 83 |
| 2023 3 | 78 | 19 | 97 |
| 2023 2 | 79 | 31 | 110 |
| 2022 1 | 68 | 46 | 114 |
| 2022 12 | 100 | 39 | 139 |
| 2022 11 | 97 | 36 | 133 |
| 2022 10 | 122 | 33 | 155 |
| 2022 9 | 58 | 44 | 102 |
| 2022 8 | 83 | 57 | 140 |
| 2022 7 | 77 | 44 | 121 |
| 2022 6 | 171 | 45 | 216 |
| 2022 5 | 163 | 58 | 221 |
| 2022 4 | 200 | 30 | 230 |
| 2022 3 | 221 | 48 | 269 |
| 2022 2 | 189 | 27 | 216 |
| 2021 1 | 185 | 45 | 230 |
| 2021 12 | 101 | 53 | 154 |
| 2021 11 | 129 | 43 | 172 |
| 2021 10 | 109 | 66 | 175 |
| 2021 9 | 55 | 42 | 97 |
| 2021 8 | 55 | 31 | 86 |
| 2021 7 | 46 | 34 | 80 |
| 2021 6 | 107 | 35 | 142 |
| 2021 5 | 72 | 67 | 139 |
| 2021 4 | 110 | 111 | 221 |
| 2021 3 | 137 | 52 | 189 |
| 2021 2 | 113 | 25 | 138 |
| 2020 1 | 79 | 17 | 96 |
| 2020 12 | 66 | 27 | 93 |
| 2020 11 | 54 | 22 | 76 |
| 2020 10 | 83 | 35 | 118 |
| 2020 9 | 85 | 28 | 113 |
| 2020 8 | 48 | 28 | 76 |
| 2020 7 | 46 | 17 | 63 |
| 2020 6 | 42 | 31 | 73 |
| 2020 5 | 34 | 27 | 61 |
| 2020 4 | 36 | 24 | 60 |
| 2020 3 | 19 | 16 | 35 |
| 2020 2 | 8 | 2 | 10 |
| 2020 1 | 7 | 4 | 11 |
| 2019 11 | 8 | 0 | 8 |
| 2019 10 | 8 | 0 | 8 |
| 2019 9 | 1 | 2 | 3 |
| 2019 8 | 1 | 0 | 1 |
| 2019 7 | 4 | 0 | 4 |
| 2019 6 | 8 | 0 | 8 |
| 2019 5 | 4 | 4 | 8 |
| 2019 4 | 2 | 4 | 6 |
| 2019 2 | 5 | 5 | 10 |
| 2019 1 | 2 | 0 | 2 |
| 2018 12 | 23 | 2 | 25 |
| 2018 11 | 9 | 6 | 15 |
| 2018 10 | 2 | 0 | 2 |
| 2018 9 | 5 | 4 | 9 |
| 2018 7 | 2 | 1 | 3 |
| 2018 6 | 1 | 1 | 2 |
| 2018 5 | 2 | 0 | 2 |
| 2018 4 | 1 | 4 | 5 |
| 2018 3 | 1 | 0 | 1 |
| 2018 2 | 15 | 3 | 18 |
| 2018 1 | 18 | 2 | 20 |
| 2017 12 | 27 | 4 | 31 |
| 2017 11 | 22 | 3 | 25 |
| 2017 10 | 8 | 5 | 13 |
| 2017 9 | 9 | 1 | 10 |
| 2017 8 | 11 | 3 | 14 |
| 2017 7 | 10 | 1 | 11 |
| 2017 6 | 11 | 1 | 12 |
| 2017 5 | 4 | 1 | 5 |
| 2017 4 | 7 | 3 | 10 |
| 2017 3 | 3 | 2 | 5 |
| 2017 2 | 51 | 11 | 62 |
| 2016 1 | 66 | 5 | 71 |
| 2016 12 | 39 | 14 | 53 |
| 2016 11 | 52 | 25 | 77 |
| 2016 10 | 0 | 3 | 3 |
| 2016 9 | 0 | 7 | 7 |
| 2016 8 | 2 | 2 | 4 |
| 2016 7 | 5 | 6 | 11 |
Mostrar todo
